Re: New Pacer--SECOND SUPPLEMENTAL JOINT CASE MANAGEMENT CONFERENCE STATEMENT

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

optymystic

Rank: President [?]

Points: 18922 [?]

Votes: 159 Score: 3.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: New Pacer--SECOND SUPPLEMENTAL JOINT CASE MANAGEMENT CONFERENCE STATEMENT

in response to

New Pacer--SECOND SUPPLEMENTAL JOINT CASE MANAGEMENT CONFERENCE STATEMENT

wolfpackvolt

posted on Nov 04, 2009 04:56PM

<Although a Reexamination Certificate was issued on July 21, 2009, with an amended Claim 29, Defendants have not yet asserted infringement of the ’584 patent in this litigation.>

I thought we pulled it then, when a recert was in the offing, attempted to reintroduce the 584 which the court rejected. (corrections welcomed) If that is true, then they worded it this way for effect, hoping the judge doesn't remember. Let's hope he does.